NTC for Covid-19 emergency: our commitment is playing an active role to support community and raising awareness

  • Apr 30, 2020

The  Covid-19 situation has been evolving: the responsibility of everyone in implementing some essential measures, such as social distancing, personal hygiene and the use of protective equipment is fundamental to prevent Covid-19’s outbreak and approach safely our future social life.

NTC grants license and distribution rights in Mexico to Laboratorios Grin S.A. de C.V

  • Apr 21, 2020

Milan, April 21, 2020 – NTC Srl, an R&D focused pharmaceutical company headquartered in Italy, has granted license and distribution rights on one of its research and development products, a fixed combination in eye drops, in Mexico to Laboratorios Grin S.A. de C.V, a wholly owned affiliate of Lupin, focused on developing, manufacturing and distributing world-class medicines and a leader in the Ophthalmology segment. 

A three day intensive Action Agenda for NTC at CPhI 2019

  • Nov 5/7, 2019

CPhIWW represents for NTC an important event to create valuable long term business with partners from all over the world.